Evinova, a leading provider of digital health solutions, has announced that it will prioritize bringing to market scaled digital technology solutions already being used by AstraZeneca in 40 countries globally. This move aims to optimize clinical trial design and delivery, reduce the time and cost of developing new medicines, bring care closer to home for patients and reduce the burden on health systems.
In addition to this, Evinova plans to pursue opportunities in digital remote patient monitoring and digital therapeutics with a pipeline of digital innovations in these areas. This will enable the company to offer a comprehensive range of digital health solutions that can improve patient outcomes and experiences.
To accelerate industry adoption and sustain its global reach, Evinova has entered into agreements with globally-leading CROs Parexel and Fortrea. These agreements will allow Evinova to offer its digital health solutions to a wide customer base, including pharmaceutical companies, biotechnology companies and healthcare providers.
Furthermore, Evinova is collaborating with Accenture and Amazon Web Services to develop innovative solutions that can help accelerate the delivery of life-changing medicines, improve the design and delivery of clinical trials for better patient experiences and outcomes, and think more holistically about patient care before, during and after treatment.
With these partnerships in place, Evinova is well-positioned to become a leading provider of digital health solutions that can revolutionize the way healthcare is delivered around the world.